Segulah sells CCS to C.B. Fleet

23 December, 2004

Stockholm December 23, 2004

Segulah II, L.P. sells CCS, Clean Chemical Sweden AB (“CCS”) to US pharmaceutical company C.B. Fleet. Completion will take place on January 7, 2005.

CCS is a leading supplier of pharmaceutical and non-pharmaceutical body care and eye care products to i.a. the Swedish state owned pharmacies Apoteket and to Boots in the U.K. The company is based in Borlõnge, Sweden. Segulah II L.P. acquired CCS in June 2003 from listed medical research company Medivir.

C.B. Fleet, headquartered in Lynchburg Virginia, is a family owned pharmaceutical company founded in 1869 and active in 82 countries around the world. C.B. Fleet has a substantial part of its business in Europe with subsidiaries in the UK, Spain and Italy.

This is a natural step in CCS’ development. C.B. Fleet and CCS have very similar business strategies and cultures. CCS will clearly be strengthened by C.B. Fleet’s product development and marketing resources” says Jonas Nilsson, CEO, CCS

The acquisition of CCS represents a milestone in CB Fleet’s international growth strategy, expanding our presence in the Nordic region while complimenting our global product portfolio with the strong CCS brand and product range. We look forward to welcoming CCS to the CB Fleet family of companies,” mentions Jeff Rowan, Executive Vice President Global Marketing & International Operations, C.B. Fleet

“There is clear industrial logic in a combination of CCS and C.B Fleet, a growing international pharmaceuticals company. We are pleased with CCS’ development and with our investment” comments Christian Sievert, Managing Partner, Segulah

For further information on CCS or C.B. Fleet please visit: or

For further information, please contact:

Jonas Nilsson, CEO
Phone: +46 (0)243-781 00, +46 (0)70-554 16 80, e-mail:

Christian Sievert, Managing Partner
Phone: +46 (0)8-442 89 50, +46 (0)708-66 96 94

HÕkan Hallberg, CFO & Partner
Phone: +46 (0)8-442 89 50, +46 (0)704-83 38 11

News Archive